Valuation: Orion Oyj

Market Cap 11.67B 13.3B 11.02B 10.04B 18.8B 1,274B 18.93B 132B 51.07B 651B 49.92B 48.84B 2,092B P/E 2026 *
20.6x
P/E 2027 * 17.5x
Enterprise Value 11.58B 13.19B 10.93B 9.96B 18.65B 1,265B 18.79B 131B 50.68B 646B 49.54B 48.47B 2,076B EV / Sales 2026 *
5.52x
EV / Sales 2027 * 4.78x
Free-Float
90.5%
Yield 2026 *
2.34%
Yield 2027 * 2.61%
1 day+0.06%
1 week+1.78%
Current month+4.87%
1 month+2.66%
3 months+18.08%
6 months+24.27%
Current year+30.32%
1 week 81.3
Extreme 81.3
84.1
1 month 78
Extreme 78
84.1
Current year 62.7
Extreme 62.7
84.1
1 year 56.5
Extreme 56.5
84.1
3 years 31.86
Extreme 31.86
84.1
5 years 31.86
Extreme 31.86
84.1
10 years 22.57
Extreme 22.57
84.1
Manager TitleAgeSince
Chief Executive Officer 59 01/11/2022
Director of Finance/CFO 50 01/05/2024
Chief Operating Officer 46 01/01/2022
Director TitleAgeSince
Director/Board Member 63 22/03/2017
Director/Board Member 65 22/03/2017
Director/Board Member 66 06/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
8/8/25 Sell

Chief Operating Officer

4,000 0.0122%
4/8/25 Sell

Executive/Senior Manager

71 0.0002%
4/8/25 Sell

Executive/Senior Manager

724 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+0.06%+1.78%+27.62%+125.41% 13.3B
+0.13%+2.65%+65.61%+114.28% 1,055B
+0.20%+0.46%+52.60%+69.24% 654B
-0.29%+0.14%+20.96%+70.93% 467B
-0.85%+0.98%+41.29%+44.38% 348B
+0.71%+4.08%+22.24%+29.51% 275B
+1.23%+0.42%+14.57%+12.13% 258B
+2.11%+7.51%+52.89%+55.37% 224B
+0.83%+0.55%+35.99%+101.70% 187B
0.00%-10.14%-29.94%-60.30% 171B
Average +0.33%+0.65%+30.38%+56.26% 365.17B
Weighted average by Cap. +0.03%+1.16%+41.48%+68.04%

Financials

2026 *2027 *
Net sales 2.1B 2.39B 1.98B 1.81B 3.38B 229B 3.4B 23.71B 9.18B 117B 8.98B 8.78B 376B 2.37B 2.71B 2.24B 2.04B 3.82B 259B 3.85B 26.83B 10.39B 132B 10.16B 9.94B 426B
Net income 566M 645M 534M 487M 912M 61.81B 918M 6.4B 2.48B 31.58B 2.42B 2.37B 101B 668M 761M 631M 575M 1.08B 72.95B 1.08B 7.55B 2.92B 37.27B 2.86B 2.8B 120B
Net Debt -89.76M -102M -84.77M -77.26M -145M -9.8B -146M -1.01B -393M -5.01B -384M -376M -16.1B -333M -379M -314M -287M -536M -36.37B -540M -3.76B -1.46B -18.58B -1.42B -1.39B -59.71B
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,000
Date Price Change Volume
25/09/26 EUR 82.95 +0.06% 106,588
24/09/26 EUR 82.90 +0.36% 120,727
23/09/26 EUR 82.60 -1.78% 108,431
22/09/26 EUR 84.10 +1.51% 218,043
21/09/26 EUR 82.85 +1.66% 116,487
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
82.95EUR
Average target price
76.67EUR
Spread / Average Target
-7.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ORNBV Stock